This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Markets Pull Back Midday on Unexpected Pending Home Sales Decline

U.S. markets moved lower on Monday after the excitement from two big merger announcements faded and weak economic data took center stage.

Jim Cramer: Twitter is a Dangerous 'Battleground Stock'

TheStreet's Jim Cramer calls Twitter a "battleground stock" which could swing higher or lower depending on its quarterly results when it reports after the close on Tuesday.

McDonald's Bans Big Macs and McNuggets in China on Meat Recall

If you've got a craving for a burger in China, then you're not lovin' this: McDonald's is pulling its beef, pork and chicken items off the menu.

Bearish Calls on DSW and Cisco, Time Warner Cable Gets Upgrade

In Monday's Analysts' Actions, Cisco and DSW get downgrades and Time Warner Cable gets an upgrade.

Walmart, Family Dollar, Coach Top Cramer's Twitter Q&A

Jim Cramer tackles viewers' Twitter questions from the floor of the New York Stock Exchange.

Real Money Previews

Rag Doll; Taking Another Crack at Citi: Best of Kass

In highlights from his trading diary of the past week, Doug Kass examines how the market has begun to look ragged, and discusses why his view of Citigroup has changed.

It May Be Tech's Turn; A Genuinely Nutty Idea: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the past week about a cautionary note on tech and strength in specialty apparel.

Cramer: In the Amazon Jungle Without a Guide

The company has no interest in giving you earnings details or a road map.

Mad Money Recap

'Mad Money' Lightning Round: I Still Believe in Rite Aid

Cramer says he's concerned about Prospect Capital and prefers St Jude Medical over Medtronic.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Rocket Stocks to Buy for August Gains

These stocks have both short-term gain catalysts and longer-term growth prospects.

3 Huge Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

5 Stocks Ready for Breakouts

These stocks look poised to break out and trade higher from current levels.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

3 Stocks Spiking on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

MainStreet

Young Americans Prefer Bank Investments, Not Stock Market

That's a problem, because younger Americans aren't going to meet their giant retirement savings burden with low-yielding cash investments.

5 Land Mines to Avoid in Funding Your 401(k)

Way too many investors make mistakes over and over again that could easily reduce the value of their 401(k) plans.

5 Ways to Hike Your IRA Contributions

IRAs are a good way to save for retirement, but they're not going to help all that much if you're not putting money into them regularly.

5 Biggest Beer Drinking States in the U.S.

Beer sales have seen better days, but the nation's thirst for it hasn't dried up. Laborers, visitors and modest taxes help these states keep the taps open.

How to Give Away Your Kids

If something happens to you, will your children be taken care of financially? Here's what you need to know about your child and will.

Biotech

Access to Horizon Pharma Drugs Cut By Two Leading PBMs

Express Scripts and CVS Caremark are the largest and second-largest pharmacy benefits managers in the U.S. Both have been aggressive with efforts to rein in ever-escalating drug prices.

FDA Rejects AcelRx Painkiller Dispensing Device (Update)

AcelRx believes it can gather all the requested information and re-submit Zalviso to the FDA before the end of the year.

MannKind Afrezza Partnership News Coming Within Weeks

MannKind must report second-quarter financials before the end of the second week in August, which sets a quasi-deadline for Afrezza partner plans.

Beyond Wall St.

Deal News

Dollar General Beats Family Dollar and Dollar Tree Put Together

Family Dollar sold out to Dollar Tree because it is getting beaten by Dollar General. So why not buy Dollar General?

Why Family Dollar Is Avoiding the Wrath Of Carl Icahn With $8.5B Dollar Tree Deal

Monday’s deal comes amid widespread underperformance across Family Dollar’s operations.

U.S. Markets Open Higher on Family Dollar, Zillow Deals

U.S. stocks are little changed at the open on Monday after a big drop on Friday. Investors are keeping a close eye on Geopolitical tensions.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer: Twitter is a Dangerous 'Battleground Stock'

TheStreet's Jim Cramer calls Twitter a "battleground stock" which could swing higher or lower depending on its quarterly results when it reports after the close on Tuesday.

Herb Greenberg

Greenberg: Ackman and Herbalife -- The Day After

Bill Ackman's presentation failed to impress investors, but it probably should have, as Ackman raised several important points.

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Zillow Bought Trulia Because 'the Stars Aligned'

Zillow announced it is buying Trulia in a $3.5 billion in a stock-for-stock transaction as both companies come from a 'mutual position of strength,' according to Zillow CEO Spencer...

Adam Feuerstein

Access to Horizon Pharma Drugs Cut By Two Leading PBMs

Express Scripts and CVS Caremark are the largest and second-largest pharmacy benefits managers in the U.S. Both have been aggressive with efforts to rein in ever-escalating drug pr...

Laurie Kulikowski

El Pollo Loco Stock Surges 60% on IPO, But Is It a Buy?

El Pollo Loco surged 60% on its first day of trading. The fast-casual chicken chain raised $107 million from pricing 7.14 million shares at $15 a share.

Dan Freed

$25 Billion Deal and JPMorgan Stumble to Aid of Bronx Homeowner

The mortgage settlement with JPMorgan and four other banks included very little cash and led one Bronx woman down a circuitous, two-year path before her loan could be modified.

Rocco Pendola

Pandora Needs to Fire Its CEO or Hire Someone to Help Him

A static, modest growth business model will do Pandora little good on Wall Street and, eventually, with listeners. It needs to innovate in more ways than one.

Ted Reed

Auto Sales Stay Frothy in July -- but S&P Spots a Debt Problem

With auto sales apparently headed for the best July and possibly the best year since 2006, S&P is concerned that recovery ratings for some suppliers lag the corporate average.

Leon Lazaroff

Comcast Is Now the Center Which the World Revolves Around

Comcast adds more broadband subscribers than forecast in its second quarter, possibly weakening its argument that it needs to acquire Time Warner Cable to defend its business.

Submit an article to us!
DOW 16,927.49 -33.08 -0.20%
S&P 500 1,974.79 -3.55 -0.18%
NASDAQ 4,434.1480 -15.4160 -0.35%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs